We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
726
PUT
Abivax
ABVX
$11.1B
| $18.2M | 0.02% |
+135,000
| New | +$14.7M |
|
727
Northern Trust
NTRS
$34.4B
| $18.1M | 0.02% |
132,183
-280,880
| -68% | -$36.9M |
|
728
Peabody Energy
BTU
$3B
| $18M | 0.02% |
607,336
+598,635
| +6,880% | +$17.6M |
|
729
Biohaven
BHVN
$2.19B
| $18M | 0.02% |
1,591,054
+1,210,180
| +318% | +$15M |
|
730
BridgeBio Pharma
BBIO
$16.6B
| $17.9M | 0.02% |
234,389
-780,288
| -77% | -$51.2M |
|
731
PUT
Global X Uranium ETF
URA
$6.19B
| $17.8M | 0.02% |
+417,000
| New | +$20.2M |
|
732
CALL
Abbott
ABT
$188B
| $17.8M | 0.02% |
142,200
+43,500
| +44% | +$5.54M |
|
733
PUT
Honeywell
HON
$77B
| $17.8M | 0.02% |
91,200
-23,600
| -21% | -$4.62M |
|
734
Relay Therapeutics
RLAY
$4.37B
| $17.8M | 0.02% |
2,099,912
+924,941
| +79% | +$6.6M |
|
735
PUT
iShares US Home Construction ETF
ITB
$2.35B
| $17.7M | 0.02% |
184,000
| – | – |
|
736
CALL
Newmont
NEM
$124B
| $17.7M | 0.02% |
177,300
+17,600
| +11% | +$1.59M |
|
737
PUT
Walmart Inc
WMT
$897B
| $17.7M | 0.02% |
158,800
+41,100
| +35% | +$4.41M |
|
738
Magnolia Oil & Gas
MGY
$6.16B
| $17.7M | 0.02% |
807,988
-969,161
| -55% | -$22M |
|
739
Wolverine World Wide
WWW
$1.55B
| $17.6M | 0.02% |
970,763
+814,457
| +521% | +$16.5M |
|
740
Disc Medicine
IRON
$3.01B
| $17.6M | 0.02% |
221,761
-116,340
| -34% | -$9.83M |
|
|
TMHC
741
DELISTED
Taylor Morrison
TMHC
| $17.6M | 0.02% |
+298,953
| New | +$18.3M |
|
|
DRUG
742
Bright Minds Biosciences
DRUG
$793M
| $17.6M | 0.02% |
225,412
+38,490
| +21% | +$2.57M |
|
743
PUT
Datadog
DDOG
$93.6B
| $17.6M | 0.02% |
129,200
+20,500
| +19% | +$3.24M |
|
744
CALL
KraneShares CSI China Internet ETF
KWEB
$5.76B
| $17.5M | 0.02% |
515,200
+116,400
| +29% | +$4.48M |
|
|
DFTX
745
Definium Therapeutics
DFTX
$5.99B
| $17.5M | 0.02% |
+1,308,115
| New | +$16.2M |
|
746
CALL
ConocoPhillips
COP
$148B
| $17.5M | 0.02% |
186,700
+74,200
| +66% | +$6.71M |
|
747
PUT
Intel
INTC
$492B
| $17.4M | 0.02% |
472,400
-263,300
| -36% | -$9.94M |
|
748
PUT
Simon Property Group
SPG
$71.5B
| $17.3M | 0.02% |
93,700
+22,200
| +31% | +$4.03M |
|
749
Toro Company
TTC
$9.4B
| $17.3M | 0.02% |
+220,257
| New | +$16.3M |
|
750
Popular Inc
BPOP
$11.1B
| $17.3M | 0.02% |
139,124
-173,323
| -55% | -$20.5M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.